Medico Remedies Ltd. (MEDICO) Share Price Declines by 9.96% Today

Medico Remedies Ltd. Share Price falls 9.96% to Rs 45.02, with a market cap of Rs 414.92 crore.

Medico Remedies Ltd. Share Price experienced a significant decline today, falling by 9.96% to Rs 45.02. This drop in share price places the company’s market capitalisation at Rs 414.92 crore. Despite

The stock opened at Rs 48.77 and reached a high of Rs 49.53 before declining to a low of Rs 44.65. The total trading volume was 12,906,38 shares, with a turnover of Rs 0.07 crore. The significant volume indicates active participation in today’s trading session, reflecting investor reactions to the price movement. As a Micro Cap stock, Medico Remedies Ltd.

Medico Remedies Ltd. (MEDICO) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 45.02
Previous Close	Rs 50
Today's Change	Rs -4.98 (-9.96%)
Day Open	Rs 48.77
Day High	Rs 49.53
Day Low	Rs 44.65
Current Volume (BSE)	16,512
BSE Traded Volume	16,512
NSE Traded Volume	12,74,126
Combined NSE + BSE Volume	12,90,638
Turnover	Rs 0.07 crore
Market Capitalisation	Rs 414.92 crore
Market Cap Category	Micro Cap

Medico Remedies Ltd. (MEDICO) traded at Rs 45.02. versus the previous close of Rs 50, a fall of 9.96%. The stock opened at Rs 48.77, reached Rs 49.53, touched Rs 44.65. Reported volume was 16,512.

Medico Remedies Ltd. (MEDICO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 414.92 crore
P/E Ratio	31.63x
P/B Ratio	5.5x
ROE	8.31%
ROCE	10.13%
EPS	Rs 1.58
Dividend Yield	0%

Medico Remedies Ltd. was valued at a P/E ratio of 31.63x, a P/B ratio of 5.5x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 8.31% and ROCE of 10.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 1.58, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Medico Remedies Ltd. has a market capitalisation of Rs 414.92 crore, positioning it within the Micro Cap category. The company’s price-to-earnings (P/E) ratio is 31.63, which is above the industry median of 25.88 but below the average of 69.32, indicating a relatively high valuation compared to its peers. The price-to-book (P/B) ratio is 5.5, significantly higher than the industry median of 1.77, suggesting that the stock may be overvalued based on its book value.

The return on equity (ROE) is 8.31%, slightly below the industry median of 10.7%, while the return on capital employed (ROCE) is 10.13%, also below the industry median of 12.98%. These figures suggest that the company is generating returns below the industry average, which may concern investors looking for strong profitability metrics.

The earnings per share (EPS) is Rs 1.58, and the company does not currently offer a dividend yield. These fundamental metrics provide a mixed picture, with high valuation ratios and below-average profitability metrics indicating potential challenges in delivering strong returns to investors. The analysis highlights the need for investors to consider both the valuation and profitability metrics when assessing the stock’s potential.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.63x
Benchmark Median P/E	25.88x
Benchmark Average P/E	69.32x
Benchmark P/E Range	3.41x to 3,364.06x
Company P/B Ratio	5.5x
Benchmark Median P/B	1.77x
Company ROE	8.31%
Benchmark Median ROE	10.7%
Company ROCE	10.13%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 414.92 crore
Benchmark Median Market Cap	Rs 146.46 crore

Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 31.63x, which is above the benchmark median of 25.88x, a difference of +22.22%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Medico Remedies Ltd. (MEDICO) has a ROE of 8.31%, which is below the benchmark median of 10.7%, a difference of -22.34%. Medico Remedies Ltd. (MEDICO) has a ROCE of 10.13%, which is below the benchmark median of 12.98%, a difference of -21.96%.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Medico Remedies Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The sector snapshot reveals that the company’s P/E ratio of 31.63 is above the industry median of 25.88, suggesting a higher valuation compared to many peers. However, it remains below the industry average of 69.32, indicating some room for growth.

The company’s P/B ratio of 5.5 is significantly higher than the industry median of 1.77, which may raise concerns about overvaluation. The ROE of 8.31% is slightly below the industry median of 10.7%, while the ROCE of 10.13% is also below the industry median of 12.98%. These metrics suggest that Medico Remedies Ltd. may face challenges in achieving profitability levels comparable to its peers.

The Healthcare sector, with 137 companies in the Pharmaceuticals & Drugs industry, presents a competitive landscape. Medico Remedies Ltd.’s market capitalisation of Rs 414.92 crore is below the industry average of Rs 491.49 crore, positioning it as a smaller player in the market. The sector’s performance and the company’s relative position highlight the importance of strategic positioning and operational efficiency in navigating the competitive environment.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,731.11	0	2.37	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.39	7.98	28.21	26.35
Panacea Biotec Ltd.	PANACEABIO	2,580.49	0	9.08	0	5.36
Beta Drugs Ltd.	BETA	2,474.26	62.88	9.95	18.65	22.17

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 31.63x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.31% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 414.92 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

In comparison to its peers, Medico Remedies Ltd. exhibits a mixed performance. The company’s P/E ratio of 31.63 is lower than Kwality Pharmaceuticals Ltd.’s 39.39 and Beta Drugs Ltd.’s 62.88, indicating a relatively lower valuation. However, it is higher than Hester Biosciences Ltd.’s 15.25 and Venus Remedies Ltd.’s 18.35, suggesting a varied competitive stance.

The company’s ROE of 8.31% is lower than Hikal Ltd.’s 15.22% and Kwality Pharmaceuticals Ltd.’s 28.21%, indicating a weaker return on equity. The ROCE of 10.13% is also below Kwality Pharmaceuticals Ltd.’s 26.35% and Beta Drugs Ltd.’s 22.17%, highlighting potential challenges in capital efficiency.

Medico Remedies Ltd.’s market capitalisation of Rs 414.92 crore is significantly lower than its peers, such as Dishman Carbogen Amcis Ltd. with Rs 2931.84 crore and Hikal Ltd. with Rs 2731.11 crore, positioning it as a smaller player in the industry. This comparison underscores the need for strategic initiatives to enhance competitive positioning and financial performance.

Why Investors Are Watching Medico Remedies Ltd.

Investors are closely monitoring Medico Remedies Ltd. due to its recent price action and market positioning. The significant price decline and elevated RSI indicate potential overvaluation concerns, while fundamental metrics provide a mixed picture of valuation and profitability.

• Price Action: Significant 9.96% decline today, surpassing Micro Cap threshold.
• Technical Position: Elevated RSI at 79.37, indicating potential overbought conditions.
• Fundamental Context: High P/E and P/B ratios, with below-average ROE and ROCE.
• Sector Positioning: Operates in a competitive Pharmaceuticals & Drugs industry.

Investors should continue to monitor Medico Remedies Ltd.’s financial performance, strategic initiatives, and market dynamics to assess its potential for future growth and profitability. The company’s ability to navigate the competitive landscape and improve its valuation and profitability metrics will be key factors to watch.

About Medico Remedies Ltd.

Medico Remedies Ltd. is a company operating in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The company is involved in the development, manufacturing, and marketing of pharmaceutical products. Its product portfolio includes a range of formulations catering to various therapeutic segments, serving both domestic and international markets.

With a focus on quality and innovation, Medico Remedies Ltd. aims to deliver effective healthcare solutions to its customers. The company’s operations are supported by a robust manufacturing infrastructure and a dedicated research and development team, enabling it to meet the evolving needs of the healthcare industry.

As a player in the competitive Pharmaceuticals & Drugs industry, Medico Remedies Ltd. faces challenges in maintaining market share and profitability. The company’s strategic initiatives, operational efficiency, and ability to adapt to industry trends will be crucial in sustaining its growth and enhancing its market position.

Track Medico Remedies Ltd. Share Price on Univest

Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors and market enthusiasts can track Medico Remedies Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, shareholding patterns, and market insights. Stay informed about the latest developments and trends in the market by following Medico Remedies Ltd. on Univest.

Frequently Asked Questions

What caused the decline in Medico Remedies Ltd. Share Price today?

Ans. The data confirms a 9.96% decline in Medico Remedies Ltd. Share Price today, but no specific company-related catalyst is identified. The price movement surpasses the Micro Cap threshold. The stock moved -9.96% during the session.

What is the current market capitalisation of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a current market capitalisation of Rs 414.92 crore, positioning it within the Micro Cap category. The company operates in the Healthcare sector. Its P/E ratio is 31.63x.

How does Medico Remedies Ltd.'s valuation compare to industry peers?

Ans. Medico Remedies Ltd.'s P/E of 31.63 is above the industry median of 25.88 but below the average of 69.32, indicating a relatively high valuation. The company trades at a P/E ratio of 31.63x.

What is Medico Remedies Ltd.'s return on equity (ROE)?

Ans. Medico Remedies Ltd. has an ROE of 8.31%, slightly below the industry median of 10.7%, indicating lower profitability compared to peers. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 10.7%.

What is the price-to-book (P/B) ratio of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a P/B ratio of 5.5, significantly higher than the industry median of 1.77, suggesting potential overvaluation. The company trades at a P/E ratio of 31.63x. Its P/B ratio is 5.5x.

How does Medico Remedies Ltd.'s ROCE compare to industry standards?

Ans. Medico Remedies Ltd.'s ROCE is 10.13%, below the industry median of 12.98%, indicating challenges in capital efficiency. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 10.7%.